Literature DB >> 22377524

Cytokine profiles in Japanese patients with chronic rhinosinusitis.

Takayuki Sejima1, Gabriele Holtappels, Hisashi Kikuchi, Shoichiro Imayoshi, Keiichi Ichimura, Claus Bachert.   

Abstract

BACKGROUND: Chronic rhinosinusitis (CRS) is classified in CRS without nasal polyp (CRSsNP) and CRS with nasal polyp (CRSwNP) in western countries, whereas this classification was not common so far in Japan. Studying inflammatory mediators in clearly defined disease subgroups may lead to a better differentiation of chronic sinus diseases.
METHODS: Homogenates of sinonasal mucosal tissue from 14 controls, 9 CRSsNP patients, and 19 CRSwNP patients were assayed for transforming growth factor (TGF)-β, interleukin (IL)-5, immunoglobulin E (IgE), Staphylococcus enterotoxin (SAE)-IgE, eosinophil-catioic protein (ECP), myeloperoxidase (MPO), IL-1β, IL-6, and IL-8 by enzyme-linked immunosorbent assay or UNICAP system.
RESULTS: CRSwNP had significantly higher levels of IL-5, IgE, SAE-IgE, and ECP compared with CRSsNP and controls. CRSsNP was characterized by high levels of TGF-β, while CRSwNP showed a Th2 polarization and lower levels of TGF-β. Especially, in CRSwNP samples, 68.4% were eosinophilic (ECP/MPO ratio >1), and 52.6% were SAE-IgE positive. On the other hand, in 9 CRSsNP patients, eosinophilic or SAE-IgE positive sample was only one sample respectively. Additionally, 31.6% of CRSwNP were asthmatic patients, while none of CRSsNP patient was suffering from bronchial asthma.
CONCLUSIONS: This study is thought to be the first one that showed the cytokine profiles in Japanese CRSs/wNP similar to those of European CRS. Based on mediator profiles, we suggest that CRSsNP and CRSwNP are distinct disease entities within the group of chronic sinus diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22377524     DOI: 10.2332/allergolint.10-OA-0290

Source DB:  PubMed          Journal:  Allergol Int        ISSN: 1323-8930            Impact factor:   5.836


  18 in total

Review 1.  Immunopathology of chronic rhinosinusitis.

Authors:  Atsushi Kato
Journal:  Allergol Int       Date:  2015-02-09       Impact factor: 5.836

2.  Mortality risk in patients with chronic rhinosinusitis and its association to asthma.

Authors:  Jeremiah A Alt; Andrew J Thomas; Karen Curtin; Jathine Wong; Luke Rudmik; Richard R Orlandi
Journal:  Int Forum Allergy Rhinol       Date:  2017-03-08       Impact factor: 3.858

Review 3.  Pediatric Severe Chronic Upper Airway Disease (P-SCUAD).

Authors:  Emmanuel P Prokopakis; Livije Kalogjera; Alexander D Karatzanis
Journal:  Curr Allergy Asthma Rep       Date:  2015-12       Impact factor: 4.806

4.  Different roles of Staphylococcus aureus enterotoxin in different subtypes of nasal polyps.

Authors:  Ke-Jia Cheng; Shen-Qing Wang; Ying-Ying Xu
Journal:  Exp Ther Med       Date:  2016-12-02       Impact factor: 2.447

Review 5.  Eosinophilic chronic rhinosinusitis in East Asians.

Authors:  En-Tong Wang; Yan Zheng; Peng-Fei Liu; Li-Juan Guo
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

Review 6.  Pathogenesis of nasal polyposis.

Authors:  K E Hulse; W W Stevens; B K Tan; R P Schleimer
Journal:  Clin Exp Allergy       Date:  2015-02       Impact factor: 5.018

7.  Computed tomographic pulmonary changes in patients with chronic rhinosinusitis.

Authors:  Bruno Hochhegger; Giordano R T Alves; Klaus L Irion; Guilherme Watte; Betina Scheeren; Robson Rottenfuser; Edson Marchiori
Journal:  Br J Radiol       Date:  2015-08-06       Impact factor: 3.039

Review 8.  Formation of nasal polyps: The roles of innate type 2 inflammation and deposition of fibrin.

Authors:  Tetsuji Takabayashi; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2020-03       Impact factor: 10.793

9.  Serum levels of specific IgE to Staphylococcus aureus enterotoxins in patients with chronic rhinosinusitis.

Authors:  Xin-Yan Cui; Jian-Liang Miao; Han-Qiang Lu; Qin-Hong Qi; X I Chen; Jin Xu; Zi-Ping Lin; Zhi-Bin Chen; Min Yin; Lei Cheng
Journal:  Exp Ther Med       Date:  2015-02-02       Impact factor: 2.447

10.  Chronic rhinosinusitis and emerging treatment options.

Authors:  Patorn Piromchai; Pornthep Kasemsiri; Supawan Laohasiriwong; Sanguansak Thanaviratananich
Journal:  Int J Gen Med       Date:  2013-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.